News
A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...
22hon MSN
Aspirin halves the risk of recurrence in patients with colorectal cancer, clinical trial finds
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...
HealthDay on MSN
Daily Aspirin Cuts Colon Cancer Recurrence Risk By Half
Key Takeaways Daily aspirin can cut in half the risk that colon cancer will come backRisk of recurrence was 55% lower in ...
Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients with PIK3 pathway alterations.
News-Medical.Net on MSN
Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results